| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Apellis Pharmaceuticals, Inc. (APLS) has 17 insiders with recent SEC Form 4 filings, including 2 buys and 13 sells. APLS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.18M | $48.30M | - | |
| CEO | 482.0K | $19.78M | - | |
| Dir | 385.0K | $15.80M | - | |
| Dir | 161.6K | $6.63M | - | |
| CFO | 152.0K | $6.24M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2019 | Francois Cedric78 | Chief Executive Officer | Sell | 5,000 | $27.28 | $136,405.00 | -0.5% | |
| Oct 15, 2019 | Francois Cedric78 | Chief Executive Officer | Sell | 5,000 | $26.31 | $131,550.62 | -0.2% | |
| Sep 25, 2019 | Deschatelets Pascal69 | Chief Operating Officer | Sell | 21,541 | $25.26 | $544,058.79 | -1.2% | |
| Sep 24, 2019 | Deschatelets Pascal69 | Chief Operating Officer | Sell | 42,460 | $24.82 | $1,053,995.38 | -1.1% | |
| Sep 16, 2019 | Francois Cedric78 | Chief Executive Officer | Sell | 5,000 | $26.59 | $132,949.12 | -0.2% | |
| Aug 29, 2019 | Sullivan Timothy Eugene85 | Chief Financial Officer | Buy | 11,699 | $29.71 | $347,629.94 | New | |
| Aug 15, 2019 | Francois Cedric78 | Chief Executive Officer | Sale+OE | 10,000 | $26.80 | $268,007.22 | -0.5% | |
| Mar 11, 2019 | Morningside Venture Investments Ltd93 | 10% Owner | Buy | 441,176 | $17.00 | $7,499,992.00 | +3.8% |